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Abstract
Background and aims: Clostridium difﬁcile infection (CDI) has traditionally been
considered a hospital acquired infection but there are a rising number of infections
in the community. This study estimates the prevalence of community-onset CDI (CO-
CDI), deﬁned as onset of symptoms in a community setting and outside the hospital,
and examines the risk factors for CO-CDI in 2—64 year-olds.
Methods: A standard questionnaire was used to retrospectively obtain information
on the CDI risk factors of 58 cases of CO-CDI diagnosed between 1st April 2008 and
31st March 2009 in a community in the South of England. Each case was reviewed
for the presence of ‘established’ risk factors for CDI, i.e., age ≥65 years, in-patient
hospital stay, and recent (within ≤4 weeks) receipt of broad spectrum antibiotics,
and other, ‘non-established’ risk factors for CDI, such as exposure to antibiotics
more than 4 weeks preceding symptom onset, out-patient and day-surgery hospital
exposure, contact with a hospitalised patient, and travel outside of the UK.
Results: Fifty-eight cases of CO-CDI were diagnosed among a total community pop-
ulation of 418,000, representing an estimated prevalence of CO-CDI of 1.29 per
10,000. All 58 cases were successfully contacted, representing a 100% response rate.
Four cases were excluded from further analysis due to co-infection with Salmonella
spp. and Campylobacter spp. Cases were more likely to be female, aged between
31 and 40 years, and present in the spring season (March—May), 2009. 46.3% (25/54)
of cases had established risk factors for CDI, 20.4% (11/54) had non-established risk
factors, 16.7% (9/54) had no risk factors and in the remaining 16.7% (9/54), available
information was insufﬁcient to classify by risk factor category.
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Conclusions: This study suggests that CDI should be included in the differential diag-
nosis of community-onset diarrhea in patients with or without established risk factors
for CDI.
dulaziz University for Health Sciences. Published by Elsevier
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the following: a history of antibiotic use over 4
weeks preceding symptoms; an out-patient or a© 2010 King Saud Bin Ab
Ltd. All rights reserved.
. Introduction
lostridium difﬁcile (C. difﬁcile) infection (CDI)
as traditionally been considered a nosocomial
nfection. Established risk factors for CDI include
ge over 65 years [1]; recent (within ≤4 weeks) in-
atient hospital or long-term care facility (LTCF)
tay [1]; recent (within ≤4 weeks) use of antimicro-
ials [1—6]; concomitant use of multiple antibiotics
1]; immunosuppression [7]; previous CDI [1]; and
nderlying medical conditions, especially those
ffecting the colonic ﬂora [1,5,7—10]. Recently CDI
as been increasingly observed in the community
etting and in individuals without established risk
actors [2,6]. Although reasons for this changing
pidemiology are not fully understood, increas-
ng host susceptibility due to novel risk factors,
igher community total antibiotic consumption,
mergence of new epidemic C. difﬁcile strains,
nd a growing reservoir of asymptomatic carriers
r colonised patients and animal reservoirs in the
ommunity are the likely explanations. [1].
CDI-related deﬁnitions in the literature vary. A
ase of healthcare-associated CDI is deﬁned as one
n which symptom onset occurs more than 48 h after
dmission to, or within 4 weeks of discharge from,
healthcare facility [12]. A case of community-
ssociated CDI (CA-CDI) is deﬁned as one in which
ymptom onset occurs within 48 h of admission and
ver 4 weeks following discharge from a healthcare
acility [12]. However, other deﬁnitions and cut-off
eriods continue to be used [5,13]. In this paper
e used ‘community-onset CDI’ (CO-CDI), to deﬁne
case of CDI with symptom onset in the community.
The aims of our study were to estimate the
revalence of CO-CDI from diarrheal samples sub-
itted from a community setting, and to identify
isk factors for CDI in individuals previously consid-
red to be at low risk.
. Methodsur study represented a retrospective, descriptive
pidemiology of CO-CDI in a community in Berk-
hire, in the South of England. The Royal Berkshire
HS Foundation Trust (RBFT) microbiology labo-
d
p
p
watory tested diarrheal samples (deﬁned as stool
aking the shape of its container) using the C. difﬁ-
ile toxins A and B enzyme immunoassay. Diarrheal
tools received from all individuals aged over 2
ears were tested for C. difﬁcile and positive cases
ere reported to the UK Department of Health
nder the Healthcare-Associated Infections manda-
ory surveillance scheme.
Our study looked at cases of CDI in 2—64-year-
ld individuals from the community diagnosed by
he RBFT microbiology laboratory between 1 April
008 and 31 March 2009. Asymptomatic carriage
f C. difﬁcile is common in children aged up to 2
ears, and children below this age were therefore
ot included. The upper age limit of 64 years was
hosen as age ≥65 years was considered an estab-
ished risk factor for developing CDI, and the aim
f the study was to explore risk factors in 2—64
ear-old individuals previously considered to be at
ow risk. Individuals (or parents/carers in cases of
hildren) who tested positive for C. difﬁcile were
ontacted by telephone by a member of the West
erkshire community infection control team and
nformation on age, symptoms, possible risk fac-
ors, medical history and drug history was collected
sing a standard proforma (see Appendix A).
CO-CDI cases were categorised into four groups
ased on the presence and type of CDI risk factors:
stablished; non-established; none; and unknown.
case with established risk factors had one or more
f the following: a history of receipt of antibiotics
n the 4 weeks preceding symptom onset; in-patient
ospital or LTCF stay in the 8 weeks preceding symp-
om onset; underlying immunosuppression; regular
se of proton pump inhibitors (PPI); underlying gas-
rointestinal conditions such as inﬂammatory bowel
isease; and a history of CDI. Non-established risk
actors were deﬁned as factors for which an asso-
iation to CDI has been proposed but not formally
stablished in the literature. A case of CO-CDI with
non-established’ risk factors had one or more ofay-surgical hospital attendance in the 8 weeks
receding symptoms; contact with a recently hos-
italised patient; and travel outside of the UK
ithin the preceding 8 weeks. A case with neither
120
‘established’ nor ‘non-established’ risk factors was
classiﬁed as having ‘none’. Finally, a case where
information on risk factors was either insufﬁcient or
unclear was classiﬁed as ‘unknown’. Collation and
basic statistical analyses of the results were carried
out with Microsoft Excel.
3. Results
In the period between 1st April 2008 and 31st March
2009, 3743 2—64 year-olds in the community were
tested for CDI by the RBFT microbiology laboratory.
Fifty-eight (1.5%) cases of CO-CDI were identiﬁed.
All 58 cases were successfully contacted by tele-
phone, giving a response rate of 100%. Four of the
58 cases tested positive for additional infectious
organisms (three tested positive for Campylobacter
spp.; one tested positive for Salmonella spp.) indi-
cating co-infection; these four cases were excluded
from further analysis. Among a total Berkshire West
population of 418,000 2—64 year-olds, this equates
to a CO-CDI prevalence of 1.29 per 10,000 popula-
tion. Overall, 25 (46.3%) of 54 cases had established
risk factors for CDI; 11 cases (20.4%) had non-
established risk factors; 9 (16.7%) cases had no risk
factors; and insufﬁcient information on risk factors
was obtained for the remaining 9 (16.7%) cases.
A summary of the sex, age and seasonal dis-
tribution of cases is shown in Table 1. CO-CDI
was more common in females than males (63% of
positive samples were from females vs. 37% from
males). Cases were most common among the age
group 31—40 years (13 cases; 24.1%), followed by
51—60 years (11 cases; 20.4%). The number of cases
peaked during the period March—May 2009, which
accounted for 40.7% of total annual activity. The
summer period of June-August 2009 saw the least
activity (8 cases; 14.8% of annual activity).
Table 2 and Fig. 1 show the distribution of risk
factors. Amongst the 25 cases with established risk
factors, receipt of antibiotics within the preceding
4 weeks was the most common risk factor, identi-
Fig. 1 Presence of risk factors in cases of CO-CDI.
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ed in 31.5% (17/54) of cases. An in-patient hospital
r LTCF stay within the preceding 8 weeks was
dentiﬁed in 13.0% (7/54) of cases. Less common
stablished risk factors were underlying immuno-
uppression, use of PPIs, underlying gastrointestinal
isease, and history of CDI. Of the 11 cases with
on-established risk factors, 4 had had an out-
atient hospital attendance or a day-case surgical
rocedure within the 8 weeks preceding symptom
nset, and a further 4 had had contact with a
ecently hospitalised patient. Three cases had trav-
lled outside of the UK in the preceding 8 weeks,
nd 2 had received antibiotics over 4 weeks preced-
ng symptom onset.
. Discussion
ur study suggests a prevalence rate of CO-CDI of
.29 cases per 10,000 population of 2—64 year-olds
n a community in the South of England. This is
omparable to ﬁgures of 1.1 per 10,000 from one
ther UK study [16] but signiﬁcantly lower than the
ndings of some other studies [6].
CDI in young, healthy females is an impor-
ant ﬁnding of our study and must be emphasised
trongly. The ﬁnding that more female than male
amples tested positive for CDI again reﬂects
he ﬁndings of other studies [12,15]. Reasons for
his gender difference are unclear but differences
n symptom interpretation, healthcare-seeking
ehaviour, and referral for specialist treatment and
nvestigations may play a role [17]. More research
s needed to investigate these possibilities further.
Less than half (46.3%) of all cases of CO-CDI were
ssociated with established risk factors. This was
signiﬁcant ﬁnding and suggests that CDI should
e considered as a differential diagnosis even in
he absence of established risk factors. Our ﬁnd-
ngs suggest that out-patient hospital exposure,
ay-case surgical procedures, contact with recently
ospitalised individuals, contact with known cases
f CDI, and travel outside of the UK might be associ-
ted with increased risk of CO-CDI. Larger and more
ystematic studies are needed to investigate these
ossible associations further.
Our study had a number of limitations. Impor-
antly, our ﬁgure of 1.29 cases of CO-CDI per 10,000
opulation represented only the minority of all
ases in a population who sought medical care and
ubmitted stool specimens for testing. Moreover,
eported cases might differ systematically from
nreported cases [18] and our sample might be
iased towards cases of CO-CDI with more severe
ymptoms. The Health Protection Agency Primary
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Table 1 Summary of case characteristics (sex, age and month of presentation).
Number Percent of total
No. of patients (2—64 years) tested 3,743
No. of cases positive for C. difﬁcile 58
Cases excludeda 4
Total cases classiﬁed as CDI 54 1.4
Sex
Male 20 37.0
Female 34 63.0
Age (years)
2—10 6 11.1
11—20 4 7.4
21—30 9 16.7
31—40 13 24.1
41—50 7 13.0
51—60 11 20.4
61—65 3 5.6
Unknown 1 1.9
Month of presentation
March—May 22 40.7
June—August 8 14.8
September-November 14 25.9
ctiou
c
s
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l
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p
aDecember-February
a Four cases excluded due to co-infection with another infe
are guidance [19] recommends testing for CDI in
peciﬁc epidemiological settings, including recent
ntibiotic or PPI use and recent hospitalisation,
hich might introduce patient selection bias for
aboratory investigation of CDI. Apart from con-
istency of stool, there are no standard selection
riteria for CDI testing [20]. Our local laboratory
rotocol included CDI testing of diarrheal stools
rom all patients over 2 years of age.
p
t
a
C
Table 2 Presence of risk factors among cases of CA-CDI.
Established Risk factorsb
Recent (within 4 weeks of symptom onset) use of antibiotics
Recent (within 8 weeks of symptom onset) overnight hospita
Immunosuppression
Use of PPI
Underlying GI disease
Previous CDI
Non-established risk factorsb
Out-patient or day-case surgical hospital attendance
Contact with a recently hospitalised patient
Travel outside the UK
Use of antibiotics (>4 weeks prior to symptom onset)
No risk factors
Unknown/insufﬁcient information
b Some cases had more than 1 risk factor.
c Calculated as percentage of total cases (n = 54).10 18.5
s organism.
The total number of cases was small, leading
o less certainty around estimates. A signiﬁcant
16.7%) proportion of questionnaires were incom-
lete or contained insufﬁcient information for
nalysis, adding further uncertainty to the inter-
retation of results. The retrospective nature of
he study raises the possibility of recall bias. Ide-
lly, controls (individuals in the community with
DI-negative diarrhea) would also have been ques-
Number Percent of totalc
25 46.3
17 31.5
l/LTCF stay 7 13.0
2 3.7
1 1.9
1 1.9
1 1.9
11 20.4
4 7.4
4 7.4
3 5.6
2 3.7
9 16.7
9 16.7
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tioned, but time and resources did not allow for
this. Data collection was limited by the standard
questionnaire, which did not speciﬁcally ask about
other potential (non-established) risk factors for
CDI. Contact with children aged less than 2 years,
for example, has been proposed as a possible risk
factor for CDI in the community but was not explic-
itly asked about in our study questionnaire.
Although it has been recommended that testing
for CDI in the community of all cases of diarrhea
among patients aged ≥2 years should be included
in the laboratory protocols for the investigation of
diarrhea [12], the evidence from this study is insuf-
ﬁcient in arguing the case either for or against this.
More research and consideration of costs and dis-
ease outcomes are required to accurately assess
whether testing for CDI signiﬁcantly affects case
management and whether it should be extended to
all patients ≥2 years. Finally, we recommend the
development of a more stringent deﬁnition of the
term ‘community-associated’ CDI. Cut-off periods
may need broadening and risk factors re-examining
in the light of new evidence. In the meantime,
community-onset CDI is a more accurate descrip-
tor of diarrhea in the community testing positive
for CDI.5. Conclusion
This study demonstrates that prevalence of CO-
CDI in this community remains low. Receipt of
A
T
Patient name:
DOB/Age:
Has the patient had any recent acute hospital admissions/visi
This CDAD episode deﬁnition: CDTa only/CDADb/PMCc
If PMC, on basis of: Sigmoidoscopy/SIRS/AXR
Toxic megacolon: Yes/No
Symptoms
Date of onset:
Previous CDT: Yes/No
Isolation: Yes/No
Comment:
Treatment
Initial treatment: None/Metronidazole/PO Vancomycin
Start/stop date:
Outcome: Refractorye/Relapsef
Adjunctive treatment
Vancomycin PO: Yes/No
Metronidazole: Yes/No
Cholestyramine: Yes/NoG. Fellmeth et al.
ntibiotics is the single most important risk factor
or CO-CDI. Nevertheless, CDI should be consid-
red as a cause of diarrhea in patients even
n the absence of traditional risk factors for
he disease. Monitoring and active surveillance
f all cases of C. difﬁcile locally, nationally and
nternationally is needed continually improve our
nderstanding of the changing epidemiology of the
isease.
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ppendix A. Clostridium difﬁcile Audit
ool
NHS Number:
GP Surgery:
ts (please include dates and facility):
Is this episode a relapsed? Yes/No
Date of CDT positive:
Date of isolation:
Was treatment successful? Yes/NoSteroids: Yes/No
IV Ig: Yes/No
EA
D
C
A
D
S
P
O
C
D
A
Rpidemiology of community-onsetClostridiumdifﬁcile infection in a community in the South of England 123
ppendix A (Continued )
rug History
hemotherapy including steroids: Yes/No
ntibiotics: Yes/No Name:
ose: Route:
tart date: Stop date:
PIs: Yes/No
ther diagnoses:
olitis: Yes/No GI Cancer: Yes/No
iverticulitis: Yes/No Other infective diagnoses:
ny additional notes:
a CDT only: positive C. difﬁcile toxin assay.
b CDAD: cases in which specimens were taken before admission of the patient to hospital or within 48 h of admission.
c PMC: pseudomembranous colitis as based on evidence of severe colitis (abdominal or radiological signs).
d Initial improvement and/or resolving of symptoms followed by renewed onset of symptoms.
e No response to treatment.
f Initial improvement and/or resolving of symptoms following treatment, followed by renewed onset of symptoms.
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